Nuance and eClinicalWorks Support AMA Guidelines with New Voice-Enabled Mobile Apps

BURLINGTON, Mass.--Nuance Communications, Inc. (NASDAQ: NUAN) today announced it has partnered with eClinicalWorks to use Nuance cloud-based medical speech recognition technology with eClinicalTouch for the iPad and eClinicalMobile for iPhone and Android, enabling clinicians working in outpatient settings to enter patient notes into the Electronic Health Record (EHR) using tablets and smartphones through a fully connected and consistent experience.

Overhauling EHR Usability“This is a major win for clinicians practicing in the ambulatory setting using our Dragon Medical solution and they are excited about the opportunity to leverage the same front-end speech recognition they know and trust to support a more efficient workflow using mobile devices,” says Jonathon Dreyer, director of mobile and cloud solutions, Nuance Communications. “We are seeing an intersection between consumer technology and health IT, and the ease-of-use that comes from these developments will help offset some of the challenges physicians are currently facing. The goal is to remove as much administrative burden from them as possible,” he adds.

Recently, the American Medical Association (AMA) called for a design overhaul of EHRs to make them easier for physicians to use in clinical settings, outlining eight priorities to improve usability. To ensure a consistent physician experience and flexible workflow with minimal disruption, eClinicalWorks has embedded Nuance speech solutions in its mobile clinical documentation apps, empowering physicians to document patient care in their own words and in the same way on eClinicalTouch and eClinicalMobile platforms.

Healthcare mobility trends are on the rise, and Nuance has seen an increased adoption of cloud-based medical speech solutions. With several thousand clinicians using both Dragon Medical 360 and eClinicalWorks in conjunction today, mobile speech is seen as a natural extension and critical component within the clinical workflow to help them produce faster, more accurate patient notes.

“Nuance cloud-based speech integrated with eClinicalTouch and eClinicalMobile will empower our users to speak right into the iPad, iPhones, and Android phones and convert speech into text, said Girish Navani, CEO and co-founder of eClinicalWorks. “eClinicalWorks Scribe will then take that text and convert it into discrete data that is searchable and reportable.”

Nuance’s medical cloud-based speech solution embedded into the eClinicalWorks mEHRs will be demonstrated at theeClinicalWorks National Users Conference, October 17- 20 in Orlando, Florida. For more information on how Nuance is creating seamless, secure mobile solutions for clinical documentation, visit poweredbynuancehealthcare.com.

About Nuance Communications, Inc.
Nuance Communications, Inc. (NASDAQ: NUAN) is a leading provider of voice and language solutions for businesses and consumers around the world. Its technologies, applications and services make the user experience more compelling by transforming the way people interact with devices and systems. Every day, millions of users and thousands of businesses experience Nuance’s proven applications. For more information, please visit:www.nuance.com. Connect with Nuance on social media through the healthcare blog, What’s next, as well as Twitterand Facebook.

Nuance and the Nuance logo are trademarks or registered trademarks of Nuance Communications, Inc. or its affiliates in the United States and/or other countries. All other company names or product names may be the trademarks of their respective owners.

The statements in this press release relating to future plans, events or services, are forward-looking statements which are subject to specific risks and uncertainties. There are a number of factors which could cause actual events or results to differ materially from those indicated in such forward looking statements, including fluctuations in demand for the Nuance products, and the continued development of Nuance products. The reader is warned not to rely on these forward-looking statements without reservation, since these are simply reflections of the current situation. Nuance disclaims any obligation to update any forward-looking statements as a result of developments occurring after the date of this document.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.